Blog Pages

Tuesday, November 9, 2010

Do You Know Someone with Macular Degeneration?

If so this message is for you…and them. There is hope. I have had the good fortune of meeting and working with physicians and scientists devoted to saving the vision of those afflicted with dry macular degeneration (AMD), diabetic retinopathy and glaucoma, as well as those that suffer from dry eye syndrome. Do you know that nutritional supplementation has been the standard of care for AMD for years?

The AREDS (Age-Related Eye Disease) Study started a revolution in the support of eye health, in spite of the fact that the antioxidant formulation used in the study was unsuccessful in mitigating vision loss in those afflicted with AMD. Then, 5 years ago, the TOZAL study results were compelling with a 76% success rate in stabilizing vision loss in as little as 6-9 months. Now, even the TOZAL study is dated science.

And as each year passes, more and more scientific evidence builds upon the last great eye health formula and has taken a giant leap into the future with the next evolution in eye care supplements, AmeriSciences OS2- “The Ocular Support Solution.” Never before has a product combined the most current scientific evidence with the superior quality of a pharmaceutical standard nutritional supplement.

I encourage you to do your research. There are many, many eye health formulas out there. Unfortunately, most are AREDS formulas that are not only based on old science or have been doctored up with random nutrients, but are made to food grade standards only. What that means, and this applies to 99% of all supplements on the market, is the only standard for a food grade vitamin is that it has to be manufactured in a sanitary environment approved for the processing of food. This includes those with the GMP stamp on the bottle.

“AmeriSciences’ OS2 is unique in that it has incorporated major scientific evidence in all areas of ocular nutrition. OS2 has a definite advantage and incorporates new findings that the scientific literature supports over the past few years that will not only help my patients who are concerned about age-related vision decline, but may help patients with other eye concerns as well,” states Dr.Robert D. Sacks, Chairman of Ophthalmology at Olympia Medical Center.

Unlike other antioxidant supplements intended to support exclusively the macula. AmeriSciences’ OS2 provides a comprehensive, multi-factorial formulation that targets the retina, the cornea, the micro- and macro-vascular structures of the eye, the lachrymal system and tear quality, visual acuity and endurance, eye strain, as well as oxidative stress and inflammation. According to Dr. Marwan Sabbagh, Chairman of the AmeriSciences Scientific Board, “This new scientifically updated formulation will become the new standard in eye health and nutrition.”

Your eyes are constantly subjected to the cell-damaging effects of free radicals and poor nutrition, which can increase the risk of developing severe vision decline or impairment. Other factors, such as diabetes, smoking and a poor diet, can also contribute to age-related vision decline. However, whether you are concerned about age related decline, dry eyes, diabetes-related ocular nutrition, or simply want to give your eye-health a boost, AmeriSciences’ OS2 is the perfect addition to your daily regimen.

I am on a mission to share AmeriSciences commitment to the most current and scientifically proven advances in the fight against age-related eye health issues. If you have a parent with AMD, which is hereditary, you are at increased risk, so it’s imperative you use supplementation for prevention. Please contact me if you or someone you know would like to receive additional information or purchase OS2.

For those readers in the eye health profession that are interested in OS2 for your patients, I welcome your call as well. I will put you in touch with practitioners experiencing immense success treating patients with AmeriSciences nutraceuticals.

In good health…

Tammy Provence

healthcheck.md@gmail.com


239-281-5899

No comments:

Post a Comment